Literature DB >> 8290894

The interaction between beta 2-microglobulin (beta 2m) and purified class-I major histocompatibility (MHC) antigen.

L O Pedersen1, A S Hansen, A C Olsen, J Gerwien, M H Nissen, S Buus.   

Abstract

The function of MHC class-I molecules is to sample peptides from the intracellular environment and present them to CD8+ cytotoxic T lymphocytes. To understand the molecular details of the assembly (and disassembly) of peptide-beta 2m-class-I complexes a biochemical peptide-class-I binding assay has been generated recently and this paper reports on a similar assay for the interaction between beta 2m and class I. As a model system human beta 2m binding to mouse class I was used. The assay is strictly biochemical using purified reagents which interact in solution and complex formation is determined by size separation. It is specific and highly sensitive. The observed affinity of the interaction, KD, is close to 0.4 nM. The rate of association at 37 degrees C is very fast (the ka is around 5 x 10(4)/M/s) whereas the dissociation is slow (the kd is around 8 x 10(-6)/s); the ratio of dissociation to association yields a calculated KD close to the observed value. At 37 degrees C almost all of the purified class I participates in binding of the exogenously offered beta 2m showing that a considerable exchange of the endogenous beta 2m occurs. Finally, it was demonstrated that exogenous beta 2m enhances binding to MHC class-I of short perfectly-matching peptides as well as longer peptides.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290894     DOI: 10.1111/j.1365-3083.1994.tb03341.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.

Authors:  Sajni Josson; Takeo Nomura; Jen-Tai Lin; Wen-Chin Huang; Daqing Wu; Haiyen E Zhau; Majd Zayzafoon; M Neale Weizmann; Murali Gururajan; Leland W K Chung
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

2.  Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay.

Authors:  Mikkel Harndahl; Michael Rasmussen; Gustav Roder; Søren Buus
Journal:  J Immunol Methods       Date:  2010-10-31       Impact factor: 2.303

3.  The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype.

Authors:  Kasper Lamberth; Gustav Røder; Mikkel Harndahl; Morten Nielsen; Claus Lundegaard; Claus Schafer-Nielsen; Ole Lund; Soren Buus
Journal:  Immunogenetics       Date:  2008-09-04       Impact factor: 2.846

4.  Distinct functions for the glycans of tapasin and heavy chains in the assembly of MHC class I molecules.

Authors:  Syed Monem Rizvi; Natasha Del Cid; Lonnie Lybarger; Malini Raghavan
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

5.  Dynamics of free versus complexed β2-microglobulin and the evolution of interfaces in MHC class I molecules.

Authors:  Chee-Seng Hee; Monika Beerbaum; Bernhard Loll; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Immunogenetics       Date:  2012-12-11       Impact factor: 2.846

6.  The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.

Authors:  Ewa Bien; Malgorzata Rapala; Malgorzata Krawczyk; Anna Balcerska
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553

7.  Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells.

Authors:  Wen-Chin Huang; Jonathan J Havel; Haiyen E Zhau; Wei Ping Qian; Hui-Wen Lue; Chia-Yi Chu; Takeo Nomura; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2008-09-01       Impact factor: 12.531

8.  Expression, refolding and crystallization of murine MHC class I H-2Db in complex with human beta2-microglobulin.

Authors:  Tatyana Sandalova; Jakob Michaëlsson; Robert A Harris; Hans-Gustaf Ljunggren; Klas Kärre; Gunter Schneider; Adnane Achour
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-11-24

9.  Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumors.

Authors:  Toshiyuki Tanaka; Terumasa Shimada; Hideo Akiyoshi; Junichiro Shimizu; Cao Zheng; Li Yijyun; Keiichiro Mie; Akiyoshi Hayashi; Mitsuru Kuwamura; Fumio Hoshi; Fumihito Ohashi
Journal:  J Vet Med Sci       Date:  2013-05-31       Impact factor: 1.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.